Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease

Abstract

Colonization with toxigenic Clostridium difficile may be associated with a wide spectrum of clinical presentation ranging from asymptomatic carriage to mild diarrhea to life-threatening colitis. Over the last 15 years, there has been a marked increase in the incidence of C. difficile infection, which predominantly affects elderly patients on antibiotics. More recently, there has been significant interest in the association between inflammatory bowel disease (IBD) and C. difficile infection. This review article discusses in some detail current knowledge of the mechanisms by which C. difficile toxins may mediate mucosal inflammation, together with the role of cell wall components of the microorganism in disease pathogenesis. Innate and adaptive host responses to C. difficile toxins and other components are described and include consideration of the potential role of known mucosal changes in IBD that may lead to an enhanced inflammatory response in the presence of C. difficile infection. Recent studies, which have characterized resident microbiota that may mediate protection against colonization by C. difficile, including their mechanisms of action, are also discussed. This includes the role of bile acids and 7α-dehydroxylase-expressing bacteria, such as Clostridium scindens. Recent studies suggest a higher carriage rate of C. difficile in patients with IBD. It is anticipated that future studies will determine the role of dysbiosis in IBD in predisposing to colonization with C. difficile.

The role of bacteria in the inflammatory bowel disease development: a narrative review

“…According to the reports, high prevalence of CDI in patients with IBD was revealed . Evidently, the toxins produced by this bacteria, inactivate the Rho family proteins which are involved in intracellular signaling pathways . The inactivation of these proteins, impairs the integrity of the membrane cytoskeleton and the barrier function of epithelial cells .…”

Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice

“…Interestingly, we found that dietary TP feeding resulted in a relative lower abundance of Clostridium in HFD‐fed mice, as compared with that of HFD alone. Clostridium has been reported to contribute to developing diseases like fatty liver, obesity, and inflammatory bowel diseases . In addition, Clostridium spp carries 7α/β‐dehydroxylation to the primary bile acids, resulting in deoxycholic acid (DCA), a secondary bile acid that may impose strong antimicrobial activity (e.g.…”

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case‐control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

“…Clostridium difficile infection is a common complication in IBD . In healthy patients, the pathogenesis of Clostridium difficile infection relies on disruption of the colonic microbiome equilibrium by antibiotic therapy . In IBD, colonic dysbiosis and exposure to immunosuppressive therapy may allow Clostridium difficile infection to develop in the absence of any antibiotic therapy.…”